Cliff Strader, Program Manager

1
Status and Outlook for the Illness and Injury
Surveillance Program

• Cliff Strader, Program Manager
• Office of Epidemiology and Health Surveillance,
  EH-53
• May 23, 2006

2
SELECTED IISP ACCOMPLISHMENTS AND CHANGES
2004-2006

• Completed 2002 Site Reports and posted to web
  site. Format change for 2003 reports planned.
• Submitted Health of the DOE Workforce
  presentation for senior management (prepared by
  Dr. Richter)
• Draft rollup report completed, short version
  under development
• Proposed nanotechnology surveillance
• Program trifold brochure updated
• Initiated work on Technical Standard for Illness
  Injury Surveillance (Jasmine Kenney)
• Initial analysis of pilot industrial hygiene
  data (Paul Wambach)
• Outbreak investigations at DOE-HQ and INL (RESL)
• Fernald left the program
• HQ pandemic flu planning

3
10 CFR PART 851 WORKER SAFETY AND HEALTH
PROGRAM, FINAL RULE
6922 Federal Register / Vol. 71, No. 27 /
Thursday, February 9, 2006 / Rules and
Regulations
DOE further notes that worker safety and health
committees and worker representatives can obtain
trend data on illness and injury and trend data
on safety from the Office of Environment, Safety
and Healths offices of Epidemiology and Health
Surveillance, Performance and Assessment,
respectively.
4
RATES OF PSYCHOLOGICAL DIAGNOSES, 1995-2002
5
ANXIETY AND NEUROSES
6
ALL PSYCHOLOGICAL DIAGNOSES RATES BY SITE AND
GENDER, 1995-2002
7
INITIAL INL AUTOIMMUNE DISEASE REPORT

• Report received August 2004
• Employee with neurologic symptoms but no specific
  diagnosis to date.
• Employee knew others at worksite with possibly
  similar conditions
• Several former RESL employees might have related
  diseases.
• Diseases included neurologic symptoms, multiple
  sclerosis, fibromyalgia, arthritis
• Could an occupational exposure be involved?

8
HEADQUARTERS CONCERNS

• Diseases not similar enough to define disease
  cluster,
• Lack of clinical diagnoses,
• Cases diagnosed over a period of approximately
  six years,
• No specific occupational exposure suspected, and
• NIOSH review concluded insufficient evidence of
  cluster to warrant investigation

9
RATE OF AUTOIMMUNE DISEASES BY AGE GROUP AVERAGED
OVER 8 YEARS, INEL VS. OTHER SITES
10
AUTOIMMUNE DISEASE AT INL VS. OTHER SITES,
1995-2002
11
WHERE TO FROM HERE?

• Site recruitment
• Technical Standard
• Dosimetry module
• Industrial Hygiene module
• Nanotechnology surveillance
• Special reports, roll-up reports, annual
  reports
• Pilot wellness projects
• HQ Pandemic Disease Surveillance